Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (65)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Granizo, J. J.
Right arrow Articles by Baquero, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Granizo, J. J.
Right arrow Articles by Baquero, F.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy (2000) 46, 959-964
© 2000 The British Society for Antimicrobial Chemotherapy

Streptococcus pyogenes resistance to erythromycin in relation to macrolide consumption in Spain (1986–1997)

Juan J. Granizoa, Lorenzo Aguilarb,*, Julio Casalc, Rafael Dal-Réb and Fernando Baquerod

a Research Area, Fundación Jiménez Díaz, Madrid; b Medical Department, SmithKline Beecham Pharmaceuticals, C/Valle de la Fuenfria no 3, 3° D. 28034 Madrid; c Microbiology Department, National Centre of Microbiology, Instituto de Salud Carlos III, Majadahonda (Madrid); d Microbiology Department, Ramón y Cajal Hospital, Madrid, Spain

The relationship between Streptococcus pyogenes resistance to erythromycin and macrolide consumption in Spain was studied. Erythromycin resistance was highly correlated with the consumption of total macrolides (r = 0.88, P < 0.01). When macrolides were grouped into posological subgroups according to their pharmacokinetic and pharmacodynamic properties and analysed separately, erythromycin resistance appeared to be related mainly to those macrolides taken twice daily (bd) (r = 0.86, P < 0.01) and those taken once daily (od) (r = 0.87, P < 0.01), but not to those taken four (qds) or three times a day (tds) (r = –0.04, P = 0.90). A progressive increase in the erythromycin resistance curve was seen after the consecutive introduction of both bd and od macrolides, which contributed to the increase in the total macrolide consumption, replacing tds macrolide prescription. Although this ecological analysis cannot establish an unequivocal causal relationship between antibiotic consumption and S. pyogenes resistance, the data are consistent with the hypothesis that widespread use of macrolides, mainly of bd and od macrolides, resulted in an increased prevalence of S. pyogenes resistant to erythromycin in Spain.

* Corresponding author. Tel: +34-91-334-5275; Fax: +34-91-334-5141; E-mail: lorenzo.aguilar-alfaro{at}sb.com


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Clin. Microbiol.Home page
A. Fenoll, J. J. Granizo, L. Aguilar, M. J. Gimenez, L. Aragoneses-Fenoll, G. Hanquet, J. Casal, and D. Tarrago
Temporal Trends of Invasive Streptococcus pneumoniae Serotypes and Antimicrobial Resistance Patterns in Spain from 1979 to 2007
J. Clin. Microbiol., April 1, 2009; 47(4): 1012 - 1020.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
S. S. Richter, K. P. Heilmann, C. L. Dohrn, S. E. Beekmann, F. Riahi, J. Garcia-de-Lomas, M. Ferech, H. Goossens, and G. V. Doern
Increasing telithromycin resistance among Streptococcus pyogenes in Europe
J. Antimicrob. Chemother., March 1, 2008; 61(3): 603 - 611.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
R. L. Woodbury, K. A. Klammer, Y. Xiong, T. Bailiff, A. Glennen, J. M. Bartkus, R. Lynfield, C. Van Beneden, B. W. Beall, and for the Active Bacterial Core Surveillance Team
Plasmid-Borne erm(T) from Invasive, Macrolide-Resistant Streptococcus pyogenes Strains
Antimicrob. Agents Chemother., March 1, 2008; 52(3): 1140 - 1143.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
B. Luca-Harari, K. Ekelund, M. van der Linden, M. Staum-Kaltoft, A. M. Hammerum, and A. Jasir
Clinical and Epidemiological Aspects of Invasive Streptococcus pyogenes Infections in Denmark during 2003 and 2004
J. Clin. Microbiol., January 1, 2008; 46(1): 79 - 86.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
E. Perez-Trallero, M. Montes, B. Orden, E. Tamayo, J. M. Garcia-Arenzana, and J. M. Marimon
Phenotypic and Genotypic Characterization of Streptococcus pyogenes Isolates Displaying the MLSB Phenotype of Macrolide Resistance in Spain, 1999 to 2005
Antimicrob. Agents Chemother., April 1, 2007; 51(4): 1228 - 1233.
[Abstract] [Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
F. Marra, D. L Monnet, D. M Patrick, M. Chong, C. T Brandt, M. Winters, M. S Kaltoft, G. J Tyrrell, M. Lovgren, and W. R Bowie
A Comparison of Antibiotic Use in Children Between Canada and Denmark
Ann. Pharmacother., April 1, 2007; 41(4): 659 - 666.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
C. V. Hawkyard and R. J. Koerner
The use of erythromycin as a gastrointestinal prokinetic agent in adult critical care: benefits versus risks
J. Antimicrob. Chemother., March 1, 2007; 59(3): 347 - 358.
[Abstract] [Full Text] [PDF]


Home page
J Med MicrobiolHome page
S. Y. Bae, J. S. Kim, J.-A. Kwon, S.-Y. Yoon, C. S. Lim, K. N. Lee, Y. Cho, Y. K. Kim, and C. K. Lee
Phenotypes and genotypes of macrolide-resistant Streptococcus pyogenes isolated in Seoul, Korea
J. Med. Microbiol., February 1, 2007; 56(2): 229 - 235.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
F. Marra, D. M. Patrick, M. Chong, and W. R. Bowie
Antibiotic use among children in British Columbia, Canada
J. Antimicrob. Chemother., October 1, 2006; 58(4): 830 - 839.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
S. Alberti, G. Cortes, C. Garcia-Rey, C. Rubio, F. Baquero, J. A. Garcia-Rodriguez, E. Bouza, L. Aguilar, and the Spanish Surveillance Group for Respiratory Pat
Streptococcus pyogenes Pharyngeal Isolates with Reduced Susceptibility to Ciprofloxacin in Spain: Mechanisms of Resistance and Clonal Diversity
Antimicrob. Agents Chemother., January 1, 2005; 49(1): 418 - 420.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
F. Marra, D. M. Patrick, R. White, H. Ng, W. R. Bowie, and J. M. Hutchinson
Effect of formulary policy decisions on antimicrobial drug utilization in British Columbia
J. Antimicrob. Chemother., January 1, 2005; 55(1): 95 - 101.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
A. Sommet, C. Sermet, P. Y. Boelle, M. Tafflet, C. Bernede, and D. Guillemot
No significant decrease in antibiotic use from 1992 to 2000, in the French community
J. Antimicrob. Chemother., August 1, 2004; 54(2): 524 - 528.
[Abstract] [Full Text] [PDF]


Home page
CLIN PEDIATRHome page
D. E. Low, M. E. Pichichero, and U. B. Schaad
Optimizing Antibacterial Therapy for Community-Acquired Respiratory Tract Infections in Children in an Era of Bacterial Resistance
Clinical Pediatrics, March 1, 2004; 43(2): 135 - 151.
[Abstract] [PDF]


Home page
J Med MicrobiolHome page
R. R. Reinert, S. Muckel, A. Al-Lahham, B. G. Spratt, A. B. Brueggemann, R. Hakenbeck, and R. Lutticken
Characterization of German penicillin non-susceptible serotype 23F pneumococci using multilocus sequence typing
J. Med. Microbiol., November 1, 2003; 52(11): 981 - 987.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
C. P. Barrozo, K. L. Russell, T. C. Smith, A. W. Hawksworth, M. A. K. Ryan, and G. C. Gray
National Department of Defense Surveillance Data for Antibiotic Resistance and emm Gene Types of Clinical Group A Streptococcal Isolates from Eight Basic Training Military Sites
J. Clin. Microbiol., October 1, 2003; 41(10): 4808 - 4811.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
G. W. Waterer, S. C. Buckingham, L. A. Kessler, M. W. Quasney, and R. G. Wunderink
Decreasing {beta}-Lactam Resistance in Pneumococci From the Memphis Region: Analysis of 2,152 Isolates From 1996 to 2001
Chest, August 1, 2003; 124(2): 519 - 525.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
M.-I. Morosini, R. Canton, E. Loza, R. del Campo, F. Almaraz, and F. Baquero
Streptococcus pyogenes isolates with characterized macrolide resistance mechanisms in Spain: in vitro activities of telithromycin and cethromycin
J. Antimicrob. Chemother., July 1, 2003; 52(1): 50 - 55.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
S. Alberti, C. Garcia-Rey, M. A. Dominguez, L. Aguilar, E. Cercenado, M. Gobernado, and A. Garcia-Perea,
Survey of emm Gene Sequences from Pharyngeal Streptococcus pyogenes Isolates Collected in Spain and Their Relationship with Erythromycin Susceptibility
J. Clin. Microbiol., June 1, 2003; 41(6): 2385 - 2390.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
J. P. Metlay, B. L. Strom, and D. A. Asch
Prior antimicrobial drug exposure: a risk factor for trimethoprim-sulfamethoxazole-resistant urinary tract infections
J. Antimicrob. Chemother., April 1, 2003; 51(4): 963 - 970.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
J. I. Alos, B. Aracil, J. Oteo, J. L. Gomez-Garces, and the Spanish Group for the Study of Infection in th
Significant increase in the prevalence of erythromycin-resistant, clindamycin- and miocamycin-susceptible (M phenotype) Streptococcus pyogenes in Spain
J. Antimicrob. Chemother., February 1, 2003; 51(2): 333 - 337.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
T. Alarcon, A. E. Vega, D. Domingo, M. J. Martinez, and M. Lopez-Brea
Clarithromycin Resistance among Helicobacter pylori Strains Isolated from Children: Prevalence and Study of Mechanism of Resistance by PCR-Restriction Fragment Length Polymorphism Analysis
J. Clin. Microbiol., January 1, 2003; 41(1): 486 - 499.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
R. Sauermann, R. Gattringer, W. Graninger, A. Buxbaum, and A. Georgopoulos
Phenotypes of macrolide resistance of group A streptococci isolated from outpatients in Bavaria and susceptibility to 16 antibiotics
J. Antimicrob. Chemother., January 1, 2003; 51(1): 53 - 57.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
C. Latorre, C. Garcia-Rey, A. Garcia-Perea, E. Perea, L. Aguilar, E. Cercenado, J. Garcia-de-Lomas, and the Spanish Surveillance Group for Respiratory Pat
Activity of six quinolones against 226 recent clinical isolates of Streptococcus pyogenes with reduced susceptibility to ciprofloxacin
J. Antimicrob. Chemother., August 1, 2002; 50(2): 301 - 303.
[Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
C. Garcia-Rey, L. Aguilar, F. Baquero, J. Casal, and J. E. Martin
Pharmacoepidemiological Analysis of Provincial Differences between Consumption of Macrolides and Rates of Erythromycin Resistance among Streptococcus pyogenes Isolates in Spain
J. Clin. Microbiol., August 1, 2002; 40(8): 2959 - 2963.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
R. R. Reinert, A. Al-Lahham, M. Lemperle, C. Tenholte, C. Briefs, S. Haupts, H. H. Gerards, and R. Lutticken
Emergence of macrolide and penicillin resistance among invasive pneumococcal isolates in Germany
J. Antimicrob. Chemother., January 1, 2002; 49(1): 61 - 68.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
C. Garcia-Rey, L. Aguilar, F. Baquero, J. Casal, and R. Dal-Re
Importance of Local Variations in Antibiotic Consumption and Geographical Differences of Erythromycin and Penicillin Resistance in Streptococcus pneumoniae
J. Clin. Microbiol., January 1, 2002; 40(1): 159 - 164.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
E. Perez-Trallero, C. Fernandez-Mazarrasa, C. Garcia-Rey, E. Bouza, L. Aguilar, J. Garcia-de-Lomas, F. Baquero, and The Spanish Surveillance Group for Respiratory Pat
Antimicrobial Susceptibilities of 1,684 Streptococcus pneumoniae and 2,039 Streptococcus pyogenes Isolates and Their Ecological Relationships: Results of a 1-Year (1998-1999) Multicenter Surveillance Study in Spain
Antimicrob. Agents Chemother., December 1, 2001; 45(12): 3334 - 3340.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.